Real-World Evidence of the Impact of a Novel Surgical Irrigant on Surgical Site Infections in Primary Total Knee Arthroplasty Performed at an Ambulatory Surgery Center
Surgical Infections · 01.04.2024 · 25 (3) · 240-246
DOI: 10.1089/sur.2023.304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Infections, online erschienen am 04.04.2024. Verfasst von Ronald W Singer. Beteiligte Einrichtung: Edgewater Surgery Center, Fort Mill, South Carolina, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Prosthesis-Related Infections, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Total knee arthroplasty (TKA) is one of the most common inpatient and outpatient surgical procedures performed in the United States and is predicted to increase 401% by 2040. Surgical site infections (SSIs) at an incidence rate of approximately 2% are costly post-operative complications in TKA. Intra-operative surgical irrigants are used to decrease contaminating microbial bioburden within the surgical site to prevent SSI. The primary objective of this retrospective study was to evaluate the impact of a novel surgical irrigant called XPERIENCE ® Advanced Surgical Irrigation (XP; Next Science, Jacksonville, FL) on SSI incidence in primary TKA performed at an ambulatory surgery center (ASC). Patients and Methods: Primary TKAs were performed at a free-standing ASC. The novel surgical irrigant was used intra-operatively to rinse away debris and micro-organisms from the surgical site. Retrospective data collation included SSI rates, complication rates, and re-admissions due to SSI within 90 days of index surgery.
Results
Among the 524 primary TKA surgeries, one peri-prosthetic joint infection (PJI) was diagnosed within 90 days of index surgery and one superficial incisional SSI was diagnosed within 30 days of index surgery. The PJI was attributed to an exogenously acquired upper respiratory tract infection rather than due to the failure of intra-operative regimes. The 0.19% PJI incidence rate indicated significant efficacy of XP in decreasing PJI. An overall complication rate of 7.82% was noted with none of the complications associated with usage of the novel surgical irrigant.
Conclusions
XPERIENCE is a promising intra-operative antimicrobial irrigant that can be easily incorporated into a broader infection prevention strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Edgewater Surgery Center, Fort Mill, South Carolina, USA.
- OrthoCarolina, Charlotte, North Carolina, USA.
Zitieren
APA
Singer, R. W. (2024). Real-World Evidence of the Impact of a Novel Surgical Irrigant on Surgical Site Infections in Primary Total Knee Arthroplasty Performed at an Ambulatory Surgery Center. Surgical Infections, 25(3), 240-246. https://doi.org/10.1089/sur.2023.304
Vancouver
Singer RW. Real-World Evidence of the Impact of a Novel Surgical Irrigant on Surgical Site Infections in Primary Total Knee Arthroplasty Performed at an Ambulatory Surgery Center. Surgical Infections. 2024;25(3):240-246. doi:10.1089/sur.2023.304
BibTeX
@article{Singer2024,
author = {Singer, Ronald W},
title = {Real-World Evidence of the Impact of a Novel Surgical Irrigant on Surgical Site Infections in Primary Total Knee Arthroplasty Performed at an Ambulatory Surgery Center},
journal = {Surgical Infections},
year = {2024},
volume = {25},
number = {3},
pages = {240--246},
doi = {10.1089/sur.2023.304}
}
EUVIMED